drugset / Trial / NCT05776121
Study of ZB001 in Chinese Patients With Thyroid Eye Disease
NaSequentialOpen-labelTreatment
Summary
The investigational drug, ZB001 is a humanized IgG1κ monoclonal antibody targeting human IGF-1R. The study is designed to evaluate the efficacy, safety, tolerability, and pharmacokinetics（PK）/pharmacodynamics (PD) profile of ZB001 in Chinese patients with Thyroid Eye Disease.
Timeline
- Start
- 2023-05-10
- Primary completion
- 2024-04-17
- Completion
- 2024-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZB001 | Monoclonal antibody | 3 mg/kg | Intravenous |
| Subject | ZB001 | Monoclonal antibody | 10 mg/kg | Intravenous |